Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
1.800
+0.040 (2.27%)
At close: Mar 12, 2026, 4:00 PM EDT
1.775
-0.025 (-1.39%)
After-hours: Mar 12, 2026, 6:49 PM EDT
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $4.04 million as of March 12, 2026. Its market cap has decreased by -63.36% in one year.
Market Cap
4.04M
Enterprise Value
-1.85M
1-Year Change
-63.36%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since August 4, 2021, Indaptus Therapeutics's market cap has decreased from $47.95M to $4.04M, a decrease of -91.58%. That is a compound annual growth rate of -41.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 3.95M | -22.56% |
| Dec 31, 2025 | 5.10M | -49.63% |
| Dec 31, 2024 | 10.12M | -31.58% |
| Dec 29, 2023 | 14.79M | 21.38% |
| Dec 30, 2022 | 12.18M | -73.92% |
| Dec 31, 2021 | 46.70M | -2.60% |
| Aug 4, 2021 | 47.95M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 4.97M |
| VivoSim Labs | 4.96M |
| Lunai Bioworks | 4.83M |
| Bio Green Med Solution | 4.66M |
| Genprex | 4.64M |
| Silo Pharma | 4.62M |
| Decoy Therapeutics | 4.39M |
| Oragenics | 4.19M |